These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 15297188)

  • 21. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.
    Ramus SJ; Elmasry K; Luo Z; Gammerman A; Lu K; Ayhan A; Singh N; McCluggage WG; Jacobs IJ; Whittaker JC; Gayther SA
    Clin Cancer Res; 2008 Sep; 14(18):5840-8. PubMed ID: 18794095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases.
    Falkenberry SS; Steinhoff MM; Gordinier M; Rappoport S; Gajewski W; Granai CO
    J Reprod Med; 1996 Oct; 41(10):713-8. PubMed ID: 8913971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 30. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failed conservative treatment of synchronous primary cancer of endometrium and ovary in a young Thai woman: a case report.
    Suwannarurk K; Bhamarapravatana K; Thaweekul Y; Mairaing K; Poomtavorn Y; Warnnissorn N; Wattanaruangkowit P
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S208-13. PubMed ID: 22619932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexisting ovarian malignancy in young women with endometrial cancer.
    Walsh C; Holschneider C; Hoang Y; Tieu K; Karlan B; Cass I
    Obstet Gynecol; 2005 Oct; 106(4):693-9. PubMed ID: 16199623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial cancer in young, normal-weight women.
    Schmeler KM; Soliman PT; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
    Gynecol Oncol; 2005 Nov; 99(2):388-92. PubMed ID: 16051336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
    Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Double primary carcinoma of the uterine corpus and ovary].
    Shen K
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):227-9, 254. PubMed ID: 8404308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four synchronous female genital malignancies: the ovary, cervix, endometrium and fallopian tube.
    Saglam A; Bozdag G; Kuzey GM; Kuçukali T; Ayhan A
    Arch Gynecol Obstet; 2008 Jun; 277(6):557-62. PubMed ID: 18066567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis.
    McMeekin DS; Burger RA; Manetta A; DiSaia P; Berman ML
    Gynecol Oncol; 1995 Oct; 59(1):81-6. PubMed ID: 7557621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.